FDA Inspection 1164256 — Octapharma Plasma, Inc.
The FDA completed an inspection of Octapharma Plasma, Inc. on Feb 16, 2022 in Wichita, KS. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Feb 16, 2022
- Fiscal Year
- 2022
- Product Type
- Biologics
- Project Area
- Vaccines and Allergenic Products
- Location
- Wichita, KS (United States)